AstraZeneca
AstraZeneca Gothenburg
Pepparedsleden 1,
431 50 Mölndal,
Sweden
erik.muellers@astrazeneca.com
AstraZeneca is a global, innovation and research-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, renal, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries. The innovative portfolio of medicines of AstraZeneca are used by millions of patients worldwide. AstraZeneca is working across biologics, small molecules, immuno- and nucleotide therapies, protein engineering and devices.
The company has 64,600 employees with approximately 8,900 employees in the R&D organization and invested 5.8 bnUSD in R&D in 2018, i.e. more than a quarter of the total revenues (21bn$). Two of the three strategic R&D centres are located in Europe, in Cambridge UK and Gothenburg Sweden. The third R&D hub is located in Gaithersburg, MD, US.